DeutschNewstral
Article
The Globe and Mail on 2015-09-25 22:52
U.S. maker of $500,000 drug challenges Ottawa’s ability to control drug prices
Related news
Alexion Pharmaceuticals Challenges Ottawa's Ability To Control Patent Drug Priceshuffingtonpost.ca
Ottawa’s plan is not working; budget ignores major economic challengescanadafreepress.com- Will Ottawa’s new plan lower Canada's high drug prices?The Globe and Mail
- Taxpayers Federation stands with Ontario as it challenges Ottawa’s carbon tax in courtcanadafreepress.com
- AOttawa’s drug-pricing changes threaten Canadians who suffer from rare diseasesasianjournal.ca
- Ottawa’s drug-pricing changes risk limiting patient access to new medicinescanadafreepress.com
Taiwan seeks Ottawa’s aid to stop drug smuggling from Canadanews.ubc.ca- Auto sector praises Ottawa’s NAFTA tactThe Globe and Mail
- Challenges plague Ottawa’s push to centralize IT services, Auditor saysThe Globe and Mail
- Taiwan seeks Ottawa’s aid in stopping drug smuggling from CanadaThe Globe and Mail
- Will Ottawa’s new plan lower Canada’s high drug prices?news.ubc.ca
- Peter Navarro is Ottawa’s worst nightmare – and he’s gaining influenceThe Globe and Mail
- Harper’s NAFTA memo could push Ottawa’s united front to crumbleThe Globe and Mail
- TCapturing Ottawa’s essencethefulcrum.ca
‘I was shocked’: Former trade minister Fast says he’s ‘concerned’ by Ottawa’s NAFTA talksbusiness.financialpost.com- Alberta Court of Appeal ruling is preview of future constitutional challenges for Ottawa’s climate policyThe Globe and Mail
- MOpposition blasts Ottawa’s borrowing, spendingmerrittherald.com
- Experts raise concerns about Ottawa’s planned crackdown on drug-impaired driversThe Globe and Mail